
Edwards Lifesciences – the leading global structural heart innovation ...
Explore the life and culture of working at Edwards Lifesciences Join our passionate and innovative teams around the world Discover a career where your work transforms patient lives Kickstart your …
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve …
Dec 23, 2025 · Edwards’ portfolio of FDA-approved transcatheter mitral and tricuspid therapies includes the PASCAL Precision mitral valve repair system and the EVOQUE tricuspid valve replacement system.
Who we are - Edwards Lifesciences
Who we are Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.
Search Jobs | Edwards Lifesciences
Edwards Lifesciences is committed to providing reasonable accommodations and adjustments to individuals with a disability or neurodivergence. If you need an accommodation or adjustment during …
Edwards Lifesciences Corp - FDA Approves Edwards Lifesciences' …
Dec 23, 2025 · Edwards’ portfolio of FDA-approved transcatheter mitral and tricuspid therapies includes the PASCAL Precision mitral valve repair system and the EVOQUE tricuspid valve replacement system.
Edwards Lifesciences Corp - Overview
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships …
Global Locations | Edwards Lifesciences
USA and Canada Main locations Global headquarters Edwards Lifesciences Corp One Edwards Way Irvine, CA 92614
Contact Us | Edwards Lifesciences
Careers at Edwards Discover an exciting career at a company dedicated to improving patient lives.
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic ...
May 1, 2025 · "This approval is a powerful opportunity to streamline patient care and improve the efficiency of the healthcare system,” said Larry Wood, Edwards’ corporate vice president and group …
Press Releases | Edwards Lifesciences
Oct 30, 2025 · Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference Read more November 09, 2025